In a report released today, Kevin O’Halloran from BMO Capital maintained a Buy rating on Hochschild Mining (HOC – Research Report), with a ...
Bank of Montreal’s consistently bullish chief investment strategist isn’t blinking as U.S. President Donald Trump’s tariff ...
Dyne Therapeutics (NASDAQ:DYN) traded higher in the premarket on Wednesday after BMO Capital Markets launched its coverage with an Outperform recommendation and a $50 per share target, citing the ...
BMO Capital raised the firm’s price target on Okta (OKTA) to $130 from $105 and keeps a Market Perform rating on the shares. The firm had been ...
A cooler-than-expected February consumer-price index is stoking a relief bounce in stock-index futures and triggered an initial surge higher in Treasurys, which pulled down yields, which move opposite ...
Focus on 42 stocks with solid dividend growth as inflation runs rampant Belski and his colleagues at BMO Capital Markets have nine investing strategy portfolios that can serve as models for ...
BMO Capital lowered the firm’s price target on Lyft (LYFT) to $15 from $18 and keeps a Market Perform rating on the shares. The company’s Q1 Bookings guidance growth of 10%-14% is below its ...
Duke Energy (NYSE:DUK – Free Report) had its price target boosted by BMO Capital Markets from $123.00 to $128.00 in a report published on Tuesday,Benzinga reports.They currently have an ...
The S&P 500 has never lost ground in the back half of the year after advancing between 10% and 15% in the first six months, according to BMO Capital Markets, citing data since 1950. The Montreal ...
https://www.tipranks.com/news/the-fly/mongodb-price-target-lowered-to-240-from-275-at-scotiabank BMO Capital lowered the firm’s price target on DoubleVerify (DV) to ...
Overall, the low yields and monthly fees offered by Wells Fargo on its checking and savings account options are weaker than BMO. Capital One has only 300 branches, but has a larger ATM network ...
3d
Fintel on MSNBMO Capital Initiates Coverage of Avidity Biosciences (RNA) with Outperform RecommendationFintel reports that on March 12, 2025, BMO Capital initiated coverage of Avidity Biosciences (NasdaqGM:RNA) with a Outperform ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results